Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1980 Apr;35(4):269–276. doi: 10.1136/thx.35.4.269

Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension.

M Honey, L Cotter, N Davies, D Denison
PMCID: PMC471268  PMID: 7434268

Abstract

Diazoxide was injected into the pulmonary artery in nine patients with primary pulmonary hypertension. There was no significant change in pulmonary artery pressure, which fell by more than 10 mmHg in only two patients. The pulmonary blood flow increased in all patients as a result of a fall in pulmonary vascular resistance (by 4 to 17 units). Systematic vasuclar resistance also fell as expected in all patients. Oral diazoxide was given to seven patients, two of whom showed sustained clinical improvement while remaining on treatment (400 to 600 mg daily). Five patients were unable to tolerate the drug, because of nausea and sickness (two), peripheral oedema requiring large doses of diuretics (four), diabetes (three), and postural hypotension (one). Hirsutes was troublesome in the two patients remaining on treatment. Diazoxide may be useful in the management of some patients with primary pulmonary hypertension, but its use is limited by the frequency of side effects. Our results suggest that examination of othe potent vasodilators may be worth while.

Full text

PDF
269

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DRESDALE D. T., MICHTOM R. J., SCHULTZ M. Recent studies in primary pulmonary hypertension, including pharmacodynamic observations on pulmonary vascular resistance. Bull N Y Acad Med. 1954 Mar;30(3):195–207. [PMC free article] [PubMed] [Google Scholar]
  2. Davies N. J., Denison D. M. The measurement of metabolic gas exchange and minute volume by mass spectrometry alone. Respir Physiol. 1979 Feb;36(2):261–267. doi: 10.1016/0034-5687(79)90029-x. [DOI] [PubMed] [Google Scholar]
  3. Kelman G. R. Digital computer subroutine for the conversion of oxygen tension into saturation. J Appl Physiol. 1966 Jul;21(4):1375–1376. doi: 10.1152/jappl.1966.21.4.1375. [DOI] [PubMed] [Google Scholar]
  4. Koch-Weser J. Diazoxide. N Engl J Med. 1976 Jun 3;294(23):1271–1273. doi: 10.1056/NEJM197606032942306. [DOI] [PubMed] [Google Scholar]
  5. Moser M. Diazoxide--an effective vasodilator in accelerated hypertension. Am Heart J. 1974 Jun;87(6):791–795. doi: 10.1016/0002-8703(74)90428-1. [DOI] [PubMed] [Google Scholar]
  6. OAKLEY C., GLICK G., LURIA M. N., SCHREINER B. F., Jr, YU P. N. Some regulatory mechanisms of the human pulmonary vascular bed. Circulation. 1962 Nov;26:917–930. doi: 10.1161/01.cir.26.5.917. [DOI] [PubMed] [Google Scholar]
  7. Pohl J. E., Thurston H., Davis D., Morgan M. Y. Successful use of oral diazoxide in the treatment of severe toxaemia of pregnancy. Br Med J. 1972 Jun 3;2(5813):568–570. doi: 10.1136/bmj.2.5813.568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pohl J. E., Thurston H. Use of diazoxide in hypertension with renal failure. Br Med J. 1971 Oct 16;4(5780):142–145. doi: 10.1136/bmj.4.5780.142. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Schreiner B. F., Jr, Murphy C. W., James D. H., Yu P. N. Effects of isoproterenol on the pulmonary blood volume in patients with valvular heart disease and primary myocardial disease. Circulation. 1968 Feb;37(2):220–231. doi: 10.1161/01.cir.37.2.220. [DOI] [PubMed] [Google Scholar]
  10. Severinghaus J. W. Blood gas calculator. J Appl Physiol. 1966 May;21(3):1108–1116. doi: 10.1152/jappl.1966.21.3.1108. [DOI] [PubMed] [Google Scholar]
  11. Shettigar U. R., Hultgren H. N., Specter M., Martin R., Davies D. H. Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med. 1976 Dec 16;295(25):1414–1415. doi: 10.1056/NEJM197612162952506. [DOI] [PubMed] [Google Scholar]
  12. WOOD P., BESTERMAN E. M., TOWERS M. K., MCILROY M. B. The effect of acetylcholine on pulmonary vascular resistance and left atrial pressure in mitral stenosis. Br Heart J. 1957 Apr;19(2):279–286. doi: 10.1136/hrt.19.2.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wang S. W., Pohl J. E., Rowlands D. J., Wade E. G. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1978 May;40(5):572–574. doi: 10.1136/hrt.40.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES